Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies.


Journal

Nutrition, metabolism, and cardiovascular diseases : NMCD
ISSN: 1590-3729
Titre abrégé: Nutr Metab Cardiovasc Dis
Pays: Netherlands
ID NLM: 9111474

Informations de publication

Date de publication:
07 06 2021
Historique:
received: 20 02 2021
accepted: 23 02 2021
pubmed: 18 5 2021
medline: 29 6 2021
entrez: 17 5 2021
Statut: ppublish

Résumé

This review represents a joint effort of the Italian Societies of Cardiology (SIC) and Diabetes (SID) to define the state of the art in a field of great clinical and scientific interest which is experiencing a moment of major cultural advancements, the cardiovascular risk management in type 2 diabetes mellitus. Consists of six chapters that examine various aspects of pathophysiology, diagnosis and therapy which in recent months have seen numerous scientific innovations and several clinical studies that require extensive sharing. The continuous evolution of our knowledge in this field confirms the great cultural vitality of these two cultural spheres, which requires, under the leadership of the scientific Societies, an ever greater and effective collaboration.

Identifiants

pubmed: 33994263
pii: S0939-4753(21)00100-9
doi: 10.1016/j.numecd.2021.02.029
pii:
doi:

Substances chimiques

Antihypertensive Agents 0
Hypoglycemic Agents 0
Hypolipidemic Agents 0
Platelet Aggregation Inhibitors 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1671-1690

Informations de copyright

Copyright © 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Angelo Avogaro (A)

Dipartimento di Medicina, Sezione di Diabete e Malattia del Metabolismo, Università di Padova, Italy.

Francesco Barillà (F)

Dipartimento di Medicina dei Sistemi, Università di Roma Tor Vergata, Italy.

Franco Cavalot (F)

SSD Malattie Metaboliche e Diabetologia, AOU San Luigi Gonzaga, Orbassano (Torino), Italy.

Agostino Consoli (A)

Department of Medicine and Ageing Sciences and CeSI-Met, University D'Annunzio, Chieti, Italy.

Massimo Federici (M)

Dipartimento di Medicina dei Sistemi, Università di Roma Tor Vergata, Italy.

Massimo Mancone (M)

Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Policlinico Umberto I (Roma), Italy.

Stefania Paolillo (S)

Dipartimento di Scienze Biomediche Avanzate, Sezione di Cardiologia, Università degli Studi di Napoli Federico II, Italy; Mediterranea Cardiocentro, Napoli, Italy.

Roberto Pedrinelli (R)

Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell'Area Critica, Università di Pisa, Italy.

Gianluca Perseghin (G)

Dipartimento di Medicina e Riabilitazione, Policlinico di Monza, Università degli Studi di Milano Bicocca, Italy.

Pasquale Perrone Filardi (P)

Dipartimento di Scienze Biomediche Avanzate, Sezione di Cardiologia, Università degli Studi di Napoli Federico II, Italy; Mediterranea Cardiocentro, Napoli, Italy.

Roberto Scicali (R)

Dipartimento di Medicina Clinica e Sperimentale, Università di Catania, Italy.

Gianfranco Sinagra (G)

Cardiovascular Department 'Ospedali Riuniti' and University of Trieste, Trieste, Italy.

Carmen Spaccarotella (C)

Division of Cardiology, University Magna Graecia, Catanzaro, Italy.

Ciro Indolfi (C)

Division of Cardiology, University Magna Graecia, Catanzaro, Italy; Mediterranea Cardiocentro, Napoli, Italy. Electronic address: indolfi@unicz.it.

Francesco Purrello (F)

Dipartimento di Medicina Clinica e Sperimentale, Università di Catania, Italy. Electronic address: francesco.purrello@unict.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH